Tucker Asset Management LLC Chembio Diagnostics, Inc. Transaction History

Tucker Asset Management LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 11, 2023	SELL	$0.25 - $0.45 $112 - $202	-450 Reduced 90.0%	50 $22,000
Q4 2022 May 11, 2023	SELL	$0.2 - $0.33 $90 - $148	-450 Reduced 90.0%	50 $10,000
Q2 2022 May 11, 2023	BUY	$0.45 - $0.8 $202 - $360	450 Added 900.0%	500 $325,000
Q1 2022 May 11, 2023	BUY	$0.66 - $1.23 $330 - $615	500 New	500 $410,000

Ticker CEMI
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 30,224,600
Description
Chembio Diagnostics, Inc., together with its subsidiaries, develops, manufactures, and commercializes point-of-care (POC) diagnostic tests that are used to detect or diagnose diseases. The company offers tests for COVID-19, HIV and Syphilis, and Zika virus. It also develops tests for malaria, dengue, chikungunya, Chagas, ebola, leishmaniasis, la...

Get notified when there are updates to the investment portfolio of Tucker Asset Management LLC, based on Form 13F filings with the SEC.

Stay updated on Tucker Asset Management LLC with notifications on news.